Antibodies to HER4, human receptor tyrosine kinase

Details Antibodies to HER4, human receptor tyrosine kinase Antibodies to HER4, human receptor tyrosine kinase

1995-06-07

1998-09-22

Hutzell, Paula K.

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

5303873, 5303877, 5303899, 53038885, 5303891, 5303917, 53038822, 5303913, 435330, 424149, A61K 3900

Patent

active

058110984

ABSTRACT:
The molecular cloning, expression, and biological characteristics of a novel receptor tyrosine kinase related to the epidermal growth factor receptor, termed HER4/p180.sup.erbB4, are described. Antibodies to HER4 are disclosed. A HER4 ligand capable of inducing cellular differentiation of breast cancer cells is also disclosed. In view of the expression of HER4 in several human cancers and in certain tissues of neuronal and muscular origin, various diagnostic and therapeutic uses of HER4-derived and HER4-related biological compositions are provided.

REFERENCES:
patent: 5367060 (1994-11-01), Vandleu et al.
Plowman et al PNAS (1993):90 pp. 1746-1750.
Plowman et al PNAS (1990):87 pp. 4905-4909.
Prigent et al Oncogene (1992):7 pp. 1273-1278.

Affiliated with

Also associated with

Rating

Antibodies to HER4, human receptor tyrosine kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to HER4, human receptor tyrosine kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to HER4, human receptor tyrosine kinase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1620119